1. The document presents the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for colon cancer.
2. It provides recommendations for the workup, findings, surgery, and subsequent treatment for various clinical presentations of colon cancer, including pedunculated or sessile polyps with invasive cancer, and suspected or proven metastatic adenocarcinoma.
3. The guidelines are developed by the NCCN Colon Cancer Panel and are intended to help clinicians make decisions around the best cancer care for their patients.
Colon cancer is the fourth most common cancer worldwide and the second leading cause of cancer deaths in the United States, causing around 65,000 deaths per year. It is more prevalent in men, with 71,420 new male cases and 64,010 new female cases estimated in 2017. In Pakistan, studies show 57% of colon cancer cases are in males in Karachi and 66% in males in Peshawar. The majority of cases are diagnosed above age 50. Risk factors include diet low in fiber and high in fat/red meat, sedentary lifestyle, obesity, smoking, and alcohol consumption. Symptoms can include changes in bowel movements, rectal bleeding, abdominal pain or cramps, and unexplained weight loss
I and 4 other classmates researched Colorectal Cancer, commonly called Colon Cancer, and presented before our class about what we learned. Our presentation covered the pathophysiology, epidemiology, risk factors, screenings, signs and symptoms, assessments and diagnostic tests, diagnostic criteria, treatments, and article on evidence based practices.
This document provides information on a 54-year-old female patient, Mrs. T, who was admitted to the hospital with complaints of intermittent constipation, loose stool, abdominal bloating and discomfort for the past 1 month. She has a history of right hemicolectomy in 2007 and colonoscopies in 2011 and 2012. Her diagnosis is cancer of the colon. The nursing diagnoses identified include alterations in comfort due to abdominal pain, emotional status due to anxiety over symptoms and treatment, nutritional status due to poor appetite and potential fall and infection risks.
Colon Cancer Presentation - My Impact StoryNikol Hamilton
The document discusses colon cancer prevention and is authored by Nikol Hamilton, MSN, RN. It describes Hamilton's personal experience with colon cancer and how it impacted her family. The objectives are to describe the impact of colorectal cancer on lifestyle behaviors, identify nutritional tools for education on prevention, and commit to increased risk assessments. The document provides information on colon cancer risks, signs, symptoms, and treatment as well as strategies for prevention advocacy, screening, and education.
Learning about health, family history and what information to collect is important! As we prepare for November as Health History Month, the holidays provide an excellent opportunity for families to share health history. This webinar will help you learn about colorectal cancer and cancer diagnosis, and what this means for you and your family. We’ll give you tools and resources that help you collect this important information.
http://fightcolorectalcancer.org/get-resources/webinar-series/
This case discusses a 35-year-old woman named Saher who is concerned about her risk of colorectal cancer due to her family history. Saher's aunts died of colorectal cancer at age 54, her father had intestinal polyps, and her grandmother had uterine cancer and died at age 48. The document discusses that colorectal cancer can be inherited through gene mutations. It explains that Saher most likely has Lynch syndrome, the most common form of hereditary colorectal cancer caused by a defective mismatch repair gene. The document recommends screening and provides prevention strategies like diet, exercise and prophylactic surgery to help manage Saher's risk and the risks to her children.
The document provides information about an upcoming webinar on colorectal cancer hosted by Fight Colorectal Cancer. The webinar will feature Dr. Edward Crane discussing various topics related to colorectal cancer including symptoms, risk factors, staging, treatment options and support services available to patients. Participants are encouraged to ask questions during the webinar and will receive a survey to provide feedback on the presentation.
Colon cancer is the fourth most common cancer worldwide and the second leading cause of cancer deaths in the United States, causing around 65,000 deaths per year. It is more prevalent in men, with 71,420 new male cases and 64,010 new female cases estimated in 2017. In Pakistan, studies show 57% of colon cancer cases are in males in Karachi and 66% in males in Peshawar. The majority of cases are diagnosed above age 50. Risk factors include diet low in fiber and high in fat/red meat, sedentary lifestyle, obesity, smoking, and alcohol consumption. Symptoms can include changes in bowel movements, rectal bleeding, abdominal pain or cramps, and unexplained weight loss
I and 4 other classmates researched Colorectal Cancer, commonly called Colon Cancer, and presented before our class about what we learned. Our presentation covered the pathophysiology, epidemiology, risk factors, screenings, signs and symptoms, assessments and diagnostic tests, diagnostic criteria, treatments, and article on evidence based practices.
This document provides information on a 54-year-old female patient, Mrs. T, who was admitted to the hospital with complaints of intermittent constipation, loose stool, abdominal bloating and discomfort for the past 1 month. She has a history of right hemicolectomy in 2007 and colonoscopies in 2011 and 2012. Her diagnosis is cancer of the colon. The nursing diagnoses identified include alterations in comfort due to abdominal pain, emotional status due to anxiety over symptoms and treatment, nutritional status due to poor appetite and potential fall and infection risks.
Colon Cancer Presentation - My Impact StoryNikol Hamilton
The document discusses colon cancer prevention and is authored by Nikol Hamilton, MSN, RN. It describes Hamilton's personal experience with colon cancer and how it impacted her family. The objectives are to describe the impact of colorectal cancer on lifestyle behaviors, identify nutritional tools for education on prevention, and commit to increased risk assessments. The document provides information on colon cancer risks, signs, symptoms, and treatment as well as strategies for prevention advocacy, screening, and education.
Learning about health, family history and what information to collect is important! As we prepare for November as Health History Month, the holidays provide an excellent opportunity for families to share health history. This webinar will help you learn about colorectal cancer and cancer diagnosis, and what this means for you and your family. We’ll give you tools and resources that help you collect this important information.
http://fightcolorectalcancer.org/get-resources/webinar-series/
This case discusses a 35-year-old woman named Saher who is concerned about her risk of colorectal cancer due to her family history. Saher's aunts died of colorectal cancer at age 54, her father had intestinal polyps, and her grandmother had uterine cancer and died at age 48. The document discusses that colorectal cancer can be inherited through gene mutations. It explains that Saher most likely has Lynch syndrome, the most common form of hereditary colorectal cancer caused by a defective mismatch repair gene. The document recommends screening and provides prevention strategies like diet, exercise and prophylactic surgery to help manage Saher's risk and the risks to her children.
The document provides information about an upcoming webinar on colorectal cancer hosted by Fight Colorectal Cancer. The webinar will feature Dr. Edward Crane discussing various topics related to colorectal cancer including symptoms, risk factors, staging, treatment options and support services available to patients. Participants are encouraged to ask questions during the webinar and will receive a survey to provide feedback on the presentation.
Colon cancer is the fourth most common cancer in the United States. It usually starts as noncancerous polyps that slowly develop into cancer over time if left untreated. Risk factors include age over 50, family history, diet high in red meat, and certain genetic conditions. Screening tests like colonoscopy can detect colon cancer early when treatment is most effective. Treatment depends on stage and may involve surgery, chemotherapy, and radiation. With early detection and treatment, colon cancer has a good prognosis of being cured.
Genetic counselor, Heather Herrmann, will dive in to the topic of Lynch Syndrome & CRC. Heather has enjoyed working in both pediatric genetics and cancer genetics throughout her career. She has focused the last eight years in the area of hereditary cancer syndromes and hereditary cancer risk assessment.
Colorectal cancer is the third most common cancer worldwide. Risk factors include age, family history, inflammatory bowel disease, diet, obesity, smoking, and diabetes. Staging involves endoscopy, CT, PET, and CEA levels. Treatment depends on stage - surgery alone for early stages, while later stages may involve chemotherapy and targeted agents. Neoadjuvant therapy can potentially downstage borderline resectable tumors. Adjuvant chemotherapy improves outcomes for stage III, while its benefit in stage II depends on risk factors. Advanced disease is typically treated with chemotherapy plus targeted agents like bevacizumab or anti-EGFR antibodies.
Colon cancer molecuar biology and epidemiology risk factorsprashantkumbhaj
Colon cancer arises from mutations in genes that regulate the Wnt signaling pathway and accumulate additional mutations over time. Key genetic changes activate oncogenes like KRAS and inactivate tumor suppressors like p53. Approximately 20% of cases involve defective DNA mismatch repair leading to microsatellite instability. Risk factors include family history, conditions like FAP and HNPCC, western diet high in red meat and low in fiber, lack of exercise, obesity, diabetes, and potentially HPV infection. NSAIDs and bisphosphonates may reduce risk while certain biomarkers like elevated CRP, leptin, and IGF levels are associated with increased risk.
Each January, the best and brightest minds in colorectal cancer research meet at the Gastrointestinal Cancers Symposium. Fight Colorectal Cancer and the Colon Cancer Alliance are partnering to bring you the big news in colorectal cancer from the 2013 symposium.
Join us to learn more about these topics:
- Can aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) keep cancer from returning?
- The relationship of body mass index (BMI) and exercise in colorectal cancer
- What scientists are learning about how your immune system can fight cancer
- The latest on what biomarkers can tell us about your cancer
- Rectal cancer treatment that is based on your biological make-up
The webinar will be led by Dr. Richard Goldberg, an internationally renowned gastrointestinal oncologist who specializes in colorectal cancer. He is a tenured professor in the Department of Internal Medicine at The Ohio State University and serves as physician-in-chief at Ohio State’s Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).
At our October webinar we spent time reviewing the importance of family history. In this webinar, we will discuss genetic and familial syndromes that are specific to colorectal cancer. We will discuss what you might look for in your family history and think about implications for prevention and management of the colorectal cancer syndromes based on this information!
About our Speakers:
Lisa Ku, MS, CGC | Certified Genetic Counselor at the University of Colorado.
Lisen Axell, MS, CGC | Certified Genetic Counselor at the University of Colorado.
RESEARCH & TREATMENT NEWS: Highlights from the 2014 GI Cancer SymposiumFight Colorectal Cancer
Each January, the brightest minds in colorectal cancer research meet at the Gastrointestinal Cancer Symposium.
Fight Colorectal Cancer and The Colon Cancer Alliance are partnering to bring you the big news in colorectal cancer from the symposium. Dr. Allyson Ocean will be presenting.
Get insights about new types of treatments on the horizon, diagnostic tests available, research for upcoming drugs/biomarkers and the way colorectal cancer is treated. We’ll take a look back and a look forward. You’re not going to want to miss it.
Oncology is the study of malignant diseases such as cancer. The oldest treatment is surgery, but now includes radiotherapy and drug treatments. Cancer prevalence is high, being the second leading cause of death in Western countries. The risk of developing certain cancers varies based on age, sex, geography, genetics, lifestyle, and environmental factors. Screening programs exist for some common cancers to facilitate earlier detection and improved treatment outcomes.
CANCER - sign & Symptoms and investigation Kundan Singh
This document discusses signs and symptoms of cancer and the importance of early detection. It notes that common cancers globally include prostate, lung, and colorectal cancers in developed countries and breast and cervical cancers in developing countries. While signs of cancer can mimic other illnesses, a high index of suspicion is important. Some red flags to watch out for include persistent coughs, unexplained weight loss, abnormal bleeding, and lumps or swelling. Thorough exams, screening tests, and biopsies when needed are crucial for diagnosis. Early detection can improve cancer outcomes.
Cancer is a leading cause of death in the US and worldwide. Some key points:
- Cancer is caused by uncontrolled growth and spread of abnormal cells. Many cancers can be prevented by avoiding risk factors like smoking, excess sun exposure, and unhealthy diet.
- In 2010, there were 1.5 million new cancer cases and 570,000 cancer deaths in the US. Cancer affects nearly all families.
- Lung cancer is a common type of cancer caused mainly by smoking cigarettes. Symptoms can include coughing up blood or persistent cough. Quitting smoking can significantly reduce lung cancer risk.
- Prevention strategies include not smoking, exercising, eating healthy, and getting regular cancer screenings. Up to 80%
Colon cancer can develop due to chromosomal instability or microsatellite instability. Presentation may be asymptomatic, or include changes in bowel habits, blood in stool, weight loss, or abdominal masses. Diagnosis involves tests such as colonoscopy, biopsy, and imaging. Treatment depends on stage and includes surgery to remove the cancerous section of colon as well as nearby lymph nodes, with the possibility of additional chemotherapy or radiation. Recurrence is common within the first few years and is monitored through cancer antigen testing, imaging and colonoscopy surveillance.
Colonoscopy Screening for Special Populationsalizain416
In a series of testimonials, a myriad of patients, previously diagnosed with colon cancer or not, defend the importance of getting Colonoscopy Screened.
For More detail Visit link below
http://gastrosymptoms.com/colonoscopy-screening-special-populations/
Cancer is a term used for diseases in which abnormal cells divide without control and are able to invade other tissues. Cancer cells can spread to other parts of the body through the blood and lymph systems. There are over 100 different types of cancer, each classified by the type of cell initially affected. Cancer is caused by genetic mutations that result in uncontrolled cell growth. Risk factors include carcinogens like tobacco, radiation, and viruses, as well as genetic predispositions and age. Cancer diagnosis involves imaging scans and biopsies to detect tumors and stage the cancer. Prevention strategies aim to reduce exposure to risk factors through vaccination, controlling tobacco and alcohol use, healthy diets, and cancer screening programs.
To share the knowledge from 2015 GI ASCO, Dr. Al Benson, one of FightCRC Medical Advisory Board members, and Andi Dwyer discuss key highlights as they pertain to colorectal cancer from the symposium and what they mean for patients.
The document provides information about oncology nursing including objectives, cancer pathophysiology, risk factors, prevention, screening, detection methods, grading and staging of cancer, common cancer types, and nursing interventions. Key points include identifying risk factors from a patient's history, formulating nursing diagnoses, utilizing interventions to maintain health, providing spiritual care, and displaying caring behavior in the delivery of cancer nursing care.
A public webinar to increase awareness on breast cancer. This presentation covers simple facts on occurrence of breast cancer, its risk factors and various symptoms besides briefly highlighting the multitude of treatment options available. Presented in simple layman terms for broad understanding.
Family First: What you need to know about family history, genetic testing, a...Fight Colorectal Cancer
Have you and your family talked about the importance of knowing your family's medical history?
Did you know that 3% of all colorectal cancers are due to a syndrome called Lynch syndrome? Having Lynch syndrome puts you at an 80% increased risk of developing colorectal cancer.
This webinar will focus more about Lynch Syndrome and other inherited syndromes as they relate to colorectal cancer.
Heather Hampel, a genetics counselor from Ohio State University will discuss the importance of knowing your family history. She'll talk about when, how and where to find a genetics counselor, and what is it you should discuss with them.
1. Colon cancer is the second and third most common cancer in males and females respectively and accounts for 9% of cancer deaths.
2. Screening and lifestyle changes have led to improved outcomes, with a 55% reduction in late-stage colon cancer cases over 3 decades from screening.
3. Adjuvant chemotherapy regimens including FOLFOX, CAPOX and XELOX have improved disease-free and overall survival rates compared to 5-FU/LV alone, particularly for stage III disease.
4. Ongoing research focuses on shortening treatment duration, identifying high-risk patients who may benefit from more intensive regimens, and incorporating molecular markers to optimize adjuvant therapy
CVS Caremark partnered with several organizations to raise awareness of colon cancer through a statewide and nationwide campaign in March 2012. The campaign included in-store radio, signs, and receipts to reach 800,000 monthly store customers. A website banner and emails targeted the 9.3 million monthly CVS.com visitors. The campaign aimed to educate the public on colon cancer and the importance of screenings through CVS's extensive consumer touchpoints.
This document provides an overview of PDH (Plesiochronous Digital Hierarchy) networks and SONET/SDH (Synchronous Optical Networking/Synchronous Digital Hierarchy) technologies. It discusses the evolution of PDH networks and their implementation, as well as the evolution of SONET/SDH. The basic units of transmission for SONET/SDH are described, including framing, interleaving, and their data rates. Differences between PDH and SONET/SDH are also outlined.
Colon cancer is the fourth most common cancer in the United States. It usually starts as noncancerous polyps that slowly develop into cancer over time if left untreated. Risk factors include age over 50, family history, diet high in red meat, and certain genetic conditions. Screening tests like colonoscopy can detect colon cancer early when treatment is most effective. Treatment depends on stage and may involve surgery, chemotherapy, and radiation. With early detection and treatment, colon cancer has a good prognosis of being cured.
Genetic counselor, Heather Herrmann, will dive in to the topic of Lynch Syndrome & CRC. Heather has enjoyed working in both pediatric genetics and cancer genetics throughout her career. She has focused the last eight years in the area of hereditary cancer syndromes and hereditary cancer risk assessment.
Colorectal cancer is the third most common cancer worldwide. Risk factors include age, family history, inflammatory bowel disease, diet, obesity, smoking, and diabetes. Staging involves endoscopy, CT, PET, and CEA levels. Treatment depends on stage - surgery alone for early stages, while later stages may involve chemotherapy and targeted agents. Neoadjuvant therapy can potentially downstage borderline resectable tumors. Adjuvant chemotherapy improves outcomes for stage III, while its benefit in stage II depends on risk factors. Advanced disease is typically treated with chemotherapy plus targeted agents like bevacizumab or anti-EGFR antibodies.
Colon cancer molecuar biology and epidemiology risk factorsprashantkumbhaj
Colon cancer arises from mutations in genes that regulate the Wnt signaling pathway and accumulate additional mutations over time. Key genetic changes activate oncogenes like KRAS and inactivate tumor suppressors like p53. Approximately 20% of cases involve defective DNA mismatch repair leading to microsatellite instability. Risk factors include family history, conditions like FAP and HNPCC, western diet high in red meat and low in fiber, lack of exercise, obesity, diabetes, and potentially HPV infection. NSAIDs and bisphosphonates may reduce risk while certain biomarkers like elevated CRP, leptin, and IGF levels are associated with increased risk.
Each January, the best and brightest minds in colorectal cancer research meet at the Gastrointestinal Cancers Symposium. Fight Colorectal Cancer and the Colon Cancer Alliance are partnering to bring you the big news in colorectal cancer from the 2013 symposium.
Join us to learn more about these topics:
- Can aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) keep cancer from returning?
- The relationship of body mass index (BMI) and exercise in colorectal cancer
- What scientists are learning about how your immune system can fight cancer
- The latest on what biomarkers can tell us about your cancer
- Rectal cancer treatment that is based on your biological make-up
The webinar will be led by Dr. Richard Goldberg, an internationally renowned gastrointestinal oncologist who specializes in colorectal cancer. He is a tenured professor in the Department of Internal Medicine at The Ohio State University and serves as physician-in-chief at Ohio State’s Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).
At our October webinar we spent time reviewing the importance of family history. In this webinar, we will discuss genetic and familial syndromes that are specific to colorectal cancer. We will discuss what you might look for in your family history and think about implications for prevention and management of the colorectal cancer syndromes based on this information!
About our Speakers:
Lisa Ku, MS, CGC | Certified Genetic Counselor at the University of Colorado.
Lisen Axell, MS, CGC | Certified Genetic Counselor at the University of Colorado.
RESEARCH & TREATMENT NEWS: Highlights from the 2014 GI Cancer SymposiumFight Colorectal Cancer
Each January, the brightest minds in colorectal cancer research meet at the Gastrointestinal Cancer Symposium.
Fight Colorectal Cancer and The Colon Cancer Alliance are partnering to bring you the big news in colorectal cancer from the symposium. Dr. Allyson Ocean will be presenting.
Get insights about new types of treatments on the horizon, diagnostic tests available, research for upcoming drugs/biomarkers and the way colorectal cancer is treated. We’ll take a look back and a look forward. You’re not going to want to miss it.
Oncology is the study of malignant diseases such as cancer. The oldest treatment is surgery, but now includes radiotherapy and drug treatments. Cancer prevalence is high, being the second leading cause of death in Western countries. The risk of developing certain cancers varies based on age, sex, geography, genetics, lifestyle, and environmental factors. Screening programs exist for some common cancers to facilitate earlier detection and improved treatment outcomes.
CANCER - sign & Symptoms and investigation Kundan Singh
This document discusses signs and symptoms of cancer and the importance of early detection. It notes that common cancers globally include prostate, lung, and colorectal cancers in developed countries and breast and cervical cancers in developing countries. While signs of cancer can mimic other illnesses, a high index of suspicion is important. Some red flags to watch out for include persistent coughs, unexplained weight loss, abnormal bleeding, and lumps or swelling. Thorough exams, screening tests, and biopsies when needed are crucial for diagnosis. Early detection can improve cancer outcomes.
Cancer is a leading cause of death in the US and worldwide. Some key points:
- Cancer is caused by uncontrolled growth and spread of abnormal cells. Many cancers can be prevented by avoiding risk factors like smoking, excess sun exposure, and unhealthy diet.
- In 2010, there were 1.5 million new cancer cases and 570,000 cancer deaths in the US. Cancer affects nearly all families.
- Lung cancer is a common type of cancer caused mainly by smoking cigarettes. Symptoms can include coughing up blood or persistent cough. Quitting smoking can significantly reduce lung cancer risk.
- Prevention strategies include not smoking, exercising, eating healthy, and getting regular cancer screenings. Up to 80%
Colon cancer can develop due to chromosomal instability or microsatellite instability. Presentation may be asymptomatic, or include changes in bowel habits, blood in stool, weight loss, or abdominal masses. Diagnosis involves tests such as colonoscopy, biopsy, and imaging. Treatment depends on stage and includes surgery to remove the cancerous section of colon as well as nearby lymph nodes, with the possibility of additional chemotherapy or radiation. Recurrence is common within the first few years and is monitored through cancer antigen testing, imaging and colonoscopy surveillance.
Colonoscopy Screening for Special Populationsalizain416
In a series of testimonials, a myriad of patients, previously diagnosed with colon cancer or not, defend the importance of getting Colonoscopy Screened.
For More detail Visit link below
http://gastrosymptoms.com/colonoscopy-screening-special-populations/
Cancer is a term used for diseases in which abnormal cells divide without control and are able to invade other tissues. Cancer cells can spread to other parts of the body through the blood and lymph systems. There are over 100 different types of cancer, each classified by the type of cell initially affected. Cancer is caused by genetic mutations that result in uncontrolled cell growth. Risk factors include carcinogens like tobacco, radiation, and viruses, as well as genetic predispositions and age. Cancer diagnosis involves imaging scans and biopsies to detect tumors and stage the cancer. Prevention strategies aim to reduce exposure to risk factors through vaccination, controlling tobacco and alcohol use, healthy diets, and cancer screening programs.
To share the knowledge from 2015 GI ASCO, Dr. Al Benson, one of FightCRC Medical Advisory Board members, and Andi Dwyer discuss key highlights as they pertain to colorectal cancer from the symposium and what they mean for patients.
The document provides information about oncology nursing including objectives, cancer pathophysiology, risk factors, prevention, screening, detection methods, grading and staging of cancer, common cancer types, and nursing interventions. Key points include identifying risk factors from a patient's history, formulating nursing diagnoses, utilizing interventions to maintain health, providing spiritual care, and displaying caring behavior in the delivery of cancer nursing care.
A public webinar to increase awareness on breast cancer. This presentation covers simple facts on occurrence of breast cancer, its risk factors and various symptoms besides briefly highlighting the multitude of treatment options available. Presented in simple layman terms for broad understanding.
Family First: What you need to know about family history, genetic testing, a...Fight Colorectal Cancer
Have you and your family talked about the importance of knowing your family's medical history?
Did you know that 3% of all colorectal cancers are due to a syndrome called Lynch syndrome? Having Lynch syndrome puts you at an 80% increased risk of developing colorectal cancer.
This webinar will focus more about Lynch Syndrome and other inherited syndromes as they relate to colorectal cancer.
Heather Hampel, a genetics counselor from Ohio State University will discuss the importance of knowing your family history. She'll talk about when, how and where to find a genetics counselor, and what is it you should discuss with them.
1. Colon cancer is the second and third most common cancer in males and females respectively and accounts for 9% of cancer deaths.
2. Screening and lifestyle changes have led to improved outcomes, with a 55% reduction in late-stage colon cancer cases over 3 decades from screening.
3. Adjuvant chemotherapy regimens including FOLFOX, CAPOX and XELOX have improved disease-free and overall survival rates compared to 5-FU/LV alone, particularly for stage III disease.
4. Ongoing research focuses on shortening treatment duration, identifying high-risk patients who may benefit from more intensive regimens, and incorporating molecular markers to optimize adjuvant therapy
CVS Caremark partnered with several organizations to raise awareness of colon cancer through a statewide and nationwide campaign in March 2012. The campaign included in-store radio, signs, and receipts to reach 800,000 monthly store customers. A website banner and emails targeted the 9.3 million monthly CVS.com visitors. The campaign aimed to educate the public on colon cancer and the importance of screenings through CVS's extensive consumer touchpoints.
This document provides an overview of PDH (Plesiochronous Digital Hierarchy) networks and SONET/SDH (Synchronous Optical Networking/Synchronous Digital Hierarchy) technologies. It discusses the evolution of PDH networks and their implementation, as well as the evolution of SONET/SDH. The basic units of transmission for SONET/SDH are described, including framing, interleaving, and their data rates. Differences between PDH and SONET/SDH are also outlined.
While T4 stage, fewer than 12 lymph nodes, and absence of MMR-D are factors considered in deciding adjuvant chemotherapy for Stage II CRC, they are not definitive standards. Currently, there are no established molecular markers that clearly identify patients with high or low risk of recurrence or benefit from chemotherapy for Stage II colon cancer. Researchers are working to develop improved algorithms incorporating clinical, pathological, and emerging molecular markers to better guide treatment decisions.
Colorectal cancer - adjuvant Rx - Nicola Tannerwelshbarbers
This document discusses treatment principles for colorectal cancer including histological staging, chemotherapy, surgery, and trials. It covers adjuvant therapies for colon and rectal cancers including chemotherapy with or without radiotherapy. It also discusses neoadjuvant treatments and timelines for administering adjuvant therapies. Key points covered include Dukes staging, 5-year survival rates by stage, aims of adjuvant therapy, and common surgeries for colon and rectal cancers.
This document discusses contact radiotherapy (Papillon) as an alternative to surgery for early stage rectal cancer. It notes that surgery is overtreatment for some early cancers and presents morbidity risks, especially in elderly patients. Contact radiotherapy delivers a high dose of localized radiation directly to the tumor and has shown good response rates with few side effects. It may allow some patients to avoid surgery and its risks. The document advocates for considering contact radiotherapy as a non-surgical option for select early stage rectal cancers based on a patient's risk factors and preferences.
Our Speacialists performs the screening to check harmful and pre-malignant cells in the body and clears to the patients that if there are variations from the norm of tumor. Visit for more detail: http://goo.gl/iK87lu
Alphabet Soup - Biomarker testing for colon and rectal cancer patients - KRAS...Fight Colorectal Cancer
- The document discusses biomarkers such as KRAS, NRAS, BRAF and their roles in predicting response to targeted therapies for metastatic colorectal cancer.
- The PRIME study showed that testing for additional RAS mutations beyond KRAS exon 2 identified more patients unlikely to benefit from anti-EGFR therapy. Around 17% of mCRC patients had non-KRAS exon 2 RAS mutations.
- The FIRE-3 study found that for patients with wild-type RAS, frontline FOLFIRI plus cetuximab resulted in improved progression-free survival and overall survival compared to FOLFIRI plus bevacizumab. Testing for all RAS mutations is
This class covers what all physicians need to know about colorectal cancer (except prevention and screening, dealt with elsewhere). It is exceedingly simple, but accurate to the best of my knowledge. It is based on Harrison's 19th, Edition.
The document summarizes evidence and guidelines for managing locally advanced rectal cancer. It discusses that neoadjuvant chemoradiation is preferred over postoperative chemoradiation based on trials showing lower local recurrence rates and less toxicity. Long-course neoadjuvant chemoradiation followed by surgery 6-8 weeks later is the standard approach. Post-treatment assessment of tumor response helps predict outcomes, with complete response indicating a good prognosis. Adjuvant chemotherapy after surgery may further improve survival based on meta-analyses of trials. Guidelines recommend a multidisciplinary, tailored approach incorporating staging, treatment response, and patient factors.
This document discusses colon cancer screening and prevention. It begins by stating that colon cancer is the third most common cancer in the US, with a lifetime risk of about 5%. Several risk factors are identified, including age, race, diet, obesity, tobacco and alcohol use, and family history. Screening options like stool tests, imaging tests, sigmoidoscopy, and colonoscopy are described. Colonoscopy is emphasized as the most sensitive screening method, allowing detection and removal of polyps. Guidelines recommend annual stool tests, sigmoidoscopy every 5 years, or colonoscopy every 10 years for average risk individuals starting at age 50. Earlier and more frequent screening is advised for those with family histories of colon cancer. The document aims to encourage screening and
Colon Cancer Awareness Advocate TrishaTrixie says " Get Your Butt Checked. It...Trisha Trixie Merrill
This document provides information about colon cancer awareness and prevention. It discusses the mission to raise awareness of colon cancer dangers and encourage screening. Key facts presented include that colon cancer rates are rising in younger adults under 50, and it is the second leading cause of cancer deaths in the US. Images show a normal colon versus one with cancer. Resources for further information are provided.
Colon cancer typically begins as a noncancerous polyp in the lining of the colon or rectum and can become cancerous over time. Risk factors include age, family history, diet high in red meat and saturated fats, obesity, smoking, and alcohol use. Screening is important, as early detection improves outcomes - average risk adults should be screened beginning at age 50. Colon cancer is staged based on how far it has spread, with treatment options including surgery, chemotherapy, and radiation depending on the stage. While early stage cancers can often be cured with surgery alone, advanced cancers are difficult to treat and the goals shift to slowing growth and managing symptoms.
Colorectal cancer is one of the most common and fatal cancers globally. Risk factors include age, family history, diet, obesity, and lack of physical activity. Screening tests like colonoscopy can detect and remove precancerous polyps, helping to prevent colorectal cancer by interrupting its typical development through the adenoma-carcinoma sequence. Modifying lifestyle factors and participating in screening are important for colorectal cancer prevention and early detection.
§ This study evaluated nivolumab in patients with metastatic squamous cell carcinoma of the anal canal (SCCA) who had progressed on at least one prior therapy.
§ Of the initial 12 patients treated with nivolumab, 9 patients (24.3%) had an objective response, meeting the threshold for expansion to additional patients.
§ The trial was then expanded to enroll 37 total patients. The overall response rate was 26.5% among evaluable patients, with 2 complete responses and 7 partial responses observed.
§ Nivolumab demonstrated promising antitumor activity in this heavily pretreated patient population with metastatic SCCA.
The document is the NCCN Clinical Practice Guidelines in Oncology for Pancreatic Adenocarcinoma from 2009. It provides guidelines for the diagnosis, treatment, and management of pancreatic cancer. The guidelines are developed by the NCCN Pancreatic Adenocarcinoma Panel and are intended to help clinicians individualize treatment for each patient based on clinical circumstances. The guidelines provide algorithms outlining recommendations for workup, treatment, and surveillance based on a patient's clinical presentation and disease stage.
The document is the NCCN Clinical Practice Guidelines in Oncology for Pancreatic Adenocarcinoma from 2009. It provides guidelines for the diagnosis, staging, treatment and management of pancreatic cancer. The guidelines are developed by the NCCN Pancreatic Adenocarcinoma Panel and are intended to help clinicians individualize treatment for each patient based on clinical circumstances.
Итоговая работа проекта Цикли в нашей жизни galina_pr
This document is an attendee list for the 6th Annual Neurocritical Care Society Meeting/UCNS Review Course as of October 10, 2008. It contains over 150 names, locations, and in some cases titles or affiliations of individuals scheduled to attend the meeting.
This document summarizes a conference held between Dana-Farber Cancer Institute and Maine Medical Center to improve coordination of cancer care for patients from Maine who receive treatment at Dana-Farber. About 50-60 patients from Maine receive stem cell transplants at Dana-Farber each year. The conference gave clinicians from both institutions a chance to discuss the patient transfer process and how to reduce obstacles. The goal was to better address the needs of patients who must travel long distances for specialized cancer treatment.
OMICS Publishing Group | Journal of Cancer Science & TherapyOMICS International
OMICS Publishing Group journal, Cancer Science & Therapy aims to provide the most reliable source of information on current research and developments in the field of cancer science and therapies. It publishes monthly issues along with current topics of cancer as special issues which covers all areas of novel cancer techniques for timely diagnosis and prevention.
The document is the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. It was published in 2003 by the National Heart, Lung, and Blood Institute and aimed to provide guidelines for preventing and managing high blood pressure. The report was developed by a committee of experts in hypertension and related fields and reviewed by additional experts. It outlines recommendations for classifying and staging hypertension, as well as treating and controlling high blood pressure.
NCCN_Guidelines_Head-and-Neck Cancer Version 2.2013 (1).pdfMellowMenais
The document summarizes updates made in Version 2.2013 of the NCCN Guidelines for Head and Neck Cancers. Global changes include revising recommendations for concurrent systemic therapy/RT and clarifying clinical staging terminology. Cancer-specific changes were made for lip, oral cavity, oropharynx, hypopharynx, nasopharynx, glottic larynx and supraglottic larynx cancers. New treatment options and clinical trial referrals were added for several cancer types. Guidance on radiation techniques was also extensively revised across cancer sites.
This document is the 7th edition of the AJCC Cancer Staging Manual published in 2010. It provides cancer staging guidelines for multiple anatomical sites developed by disease site-specific task forces. The manual is published by the American Joint Committee on Cancer (AJCC) with support from several cancer organizations. It includes general information on cancer staging and survival analysis, as well as specific staging guidelines for various cancer types located in the head and neck, digestive system, thorax, musculoskeletal sites, skin, breast, gynecologic sites, genitourinary sites, ophthalmic sites, central nervous system, and lymphoid neoplasms.
The University of Virginia Department of Medicine is hosting the 38th Annual Recent Advances in Clinical Medicine Conference from October 26-28, 2011 at the Omni Charlottesville Hotel. The conference will feature lectures on current issues in both outpatient and inpatient care, as well as interdisciplinary sessions on topics such as sleep disorders, joint replacement, and caring for pregnant patients. Attendees will have opportunities to ask questions and discuss cases with speakers. The conference aims to provide practical information that physicians can apply in their practices. It is designed for generalists but also specialists staying updated in their fields.
21st Century Pharmacare to Optimize Access to 21st Century Therapies
Panel B: Not-so-Rare Therapies (Yesterday, Today, Tomorrow)
Moderator: Durhane Wong-Rieger, CORD
Panelists: Lisa Machado, Canadian CML Network; Jim Whitlock, The Hospital for Sick Children; John Kuruvilla, Princess Margaret Hospital; Aleksandar Ivovic, Diabetes Patient Advocate; Joanne Lewis, Diabetes Canada; Louise Binder, HIV Patient Advocate; Nancy Durand, Sunnybrook Health Sciences Centre
This lecture series is designed to provide oncologists, physicians and medical professionals involved in cancer research, diagnosis and treatment with reviews of the latest developments in oncology. Over the course of several months, the series will feature presentations on topics such as new vaccine strategies in lymphoma management, infectious disease complications in immunocompromised oncology patients, updates on breast radiotherapy, treatment options for Hodgkin lymphoma, management of large cell lymphoma, and prognostic models in lymphoma. The goal is for participants to learn about current and new cancer therapies, research findings, treatments, and treatment plans to improve patient care.
The document provides updates from various departments at the Kimmel Cancer Center. It announces new treatments for prostate cancer including high intensity focused ultrasound. It highlights advances in areas like radiation oncology, integrative medicine, and stem cell research. It recognizes support from donors and announces new rankings for cancer care.
This document provides information about the fifth edition of the textbook "Cancer of the Head and Neck" including contributors and editors. The textbook is edited by Jeffrey N. Myers, Ehab Y. N. Hanna, and Eugene N. Myers from The University of Texas MD Anderson Cancer Center and provides information on head and neck cancer for medical professionals.
This document provides biographical information on Theresa Swift-Scanlan, including her education, positions, honors, and contributions to science. It summarizes that she has developed a research program in molecular markers for complex illnesses like breast cancer and bipolar disorder. Her work has resulted in over 30 high impact publications and she has received funding from NIH and foundations. Her goal is to understand how genetic and epigenetic markers can guide prevention and treatment to improve health outcomes.
Best Practices in Cancer Survivorship and Supportive CareAkinAkinsanya
"Early detection, better diagnostic tools, and more effective treatments are resulting in long-term cancer survivorship, with 62% of adults and 77% of pediatric cancer patients now living more than 5 years beyond their initial diagnosis.
While survival rates are rising…according to the National Cancer Institute there are nearly 12 million cancer survivors in the United States. The hurdle now facing many cancer survivors is how to achieve long-term quality of life after treatment has ended. According to the National Action Plan for Cancer Survivorship, fully one-third of survivors say they experience ongoing physical, psychological, or financial consequences of their cancer diagnosis and treatment.
Recognizing the need for a comprehensive approach to long-term survivorship care, many academic medical centers, community hospitals and oncologists in private practices are developing survivorship care programs to manage the ongoing care of their patients. In planning survivorship services, however, we need to delineate survivorship from other periods of care, so we take a pragmatic approach and define survivorship as the period in which patients treated with curative intent have completed their initial therapy and require follow-up care.”
The document is a curriculum vitae for Dr. Sachin Jogal, an Assistant Professor of Pediatrics specializing in hematology, oncology, and bone marrow transplant. It details his education, including undergraduate and medical degrees, as well as his postgraduate training and fellowships. It also lists his faculty appointments, awards, publications, presentations, committee involvement, and community service activities.
Downloadable slides highlighting key concepts in colorectal cancer screening and appropriate therapy selection and application in the adjuvant setting and beyond.
This document provides clinical guidelines for the identification, evaluation, and treatment of overweight and obesity in adults. An expert panel was convened by the National Heart, Lung, and Blood Institute and the National Institute of Diabetes and Digestive and Kidney Diseases to develop the guidelines based on a thorough review of scientific evidence. The guidelines examine the health risks of overweight and obesity and various treatment strategies, providing recommendations to help practitioners effectively assess and treat overweight and obese patients.
Dr. B. Hannah Ortiz is a gynecologic oncologist seeking an academic position. She has over 15 years of experience as a physician administrator and medical entrepreneur. She established the first practice of gynecologic oncology in an underserved area and implemented new technologies and clinical standards. She currently holds positions as Chief of Gynecology and Clinical Assistant Professor while maintaining a busy clinical practice.
A Visual Guide to 1 Samuel | A Tale of Two HeartsSteve Thomason
These slides walk through the story of 1 Samuel. Samuel is the last judge of Israel. The people reject God and want a king. Saul is anointed as the first king, but he is not a good king. David, the shepherd boy is anointed and Saul is envious of him. David shows honor while Saul continues to self destruct.
This document provides an overview of wound healing, its functions, stages, mechanisms, factors affecting it, and complications.
A wound is a break in the integrity of the skin or tissues, which may be associated with disruption of the structure and function.
Healing is the body’s response to injury in an attempt to restore normal structure and functions.
Healing can occur in two ways: Regeneration and Repair
There are 4 phases of wound healing: hemostasis, inflammation, proliferation, and remodeling. This document also describes the mechanism of wound healing. Factors that affect healing include infection, uncontrolled diabetes, poor nutrition, age, anemia, the presence of foreign bodies, etc.
Complications of wound healing like infection, hyperpigmentation of scar, contractures, and keloid formation.
Leveraging Generative AI to Drive Nonprofit InnovationTechSoup
In this webinar, participants learned how to utilize Generative AI to streamline operations and elevate member engagement. Amazon Web Service experts provided a customer specific use cases and dived into low/no-code tools that are quick and easy to deploy through Amazon Web Service (AWS.)
This presentation was provided by Racquel Jemison, Ph.D., Christina MacLaughlin, Ph.D., and Paulomi Majumder. Ph.D., all of the American Chemical Society, for the second session of NISO's 2024 Training Series "DEIA in the Scholarly Landscape." Session Two: 'Expanding Pathways to Publishing Careers,' was held June 13, 2024.
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...PECB
Denis is a dynamic and results-driven Chief Information Officer (CIO) with a distinguished career spanning information systems analysis and technical project management. With a proven track record of spearheading the design and delivery of cutting-edge Information Management solutions, he has consistently elevated business operations, streamlined reporting functions, and maximized process efficiency.
Certified as an ISO/IEC 27001: Information Security Management Systems (ISMS) Lead Implementer, Data Protection Officer, and Cyber Risks Analyst, Denis brings a heightened focus on data security, privacy, and cyber resilience to every endeavor.
His expertise extends across a diverse spectrum of reporting, database, and web development applications, underpinned by an exceptional grasp of data storage and virtualization technologies. His proficiency in application testing, database administration, and data cleansing ensures seamless execution of complex projects.
What sets Denis apart is his comprehensive understanding of Business and Systems Analysis technologies, honed through involvement in all phases of the Software Development Lifecycle (SDLC). From meticulous requirements gathering to precise analysis, innovative design, rigorous development, thorough testing, and successful implementation, he has consistently delivered exceptional results.
Throughout his career, he has taken on multifaceted roles, from leading technical project management teams to owning solutions that drive operational excellence. His conscientious and proactive approach is unwavering, whether he is working independently or collaboratively within a team. His ability to connect with colleagues on a personal level underscores his commitment to fostering a harmonious and productive workplace environment.
Date: May 29, 2024
Tags: Information Security, ISO/IEC 27001, ISO/IEC 42001, Artificial Intelligence, GDPR
-------------------------------------------------------------------------------
Find out more about ISO training and certification services
Training: ISO/IEC 27001 Information Security Management System - EN | PECB
ISO/IEC 42001 Artificial Intelligence Management System - EN | PECB
General Data Protection Regulation (GDPR) - Training Courses - EN | PECB
Webinars: https://pecb.com/webinars
Article: https://pecb.com/article
-------------------------------------------------------------------------------
For more information about PECB:
Website: https://pecb.com/
LinkedIn: https://www.linkedin.com/company/pecb/
Facebook: https://www.facebook.com/PECBInternational/
Slideshare: http://www.slideshare.net/PECBCERTIFICATION